Clinical supply fragility can delay trials, erode value, and expose hidden risks. Strong planning and resilient networks are now critical for success.
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
When Protocol Amendments Meet RTSM: From Headache To High-Performance
Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
Key Considerations For Labeling Your Cell Or Gene Therapy
As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
Overcoming Inventory Challenges For A Complex, Global Study
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
Managing Complex Global Drug Distribution And Expiry
A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced.
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Integrating Early-Phase Clinical Supply Manufacturing & Distribution
A tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.
-
Enhancing Clinical Supply Chain With Signant SmartSignals Supplies
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Developmental Testing Of IV Solutions
As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.